Skip to main content
PMC home page
Biochemical Journal logoLink to Biochemical Journal
. 1996 Jun 15;316(Pt 3):813–817. doi: 10.1042/bj3160813

Recombinant human tumour necrosis factor-alpha suppresses synthesis, activity and secretion of lipoprotein lipase in cultures of a human osteosarcoma cell line.

K Sakayama 1, H Masuno 1, H Okumura 1, T Shibata 1, H Okuda 1
PMCID: PMC1217422  PMID: 8670156

Abstract

The effect of recombinant human tumour necrosis factor-alpha (TNF-alpha) on synthesis, activity and secretion of lipoprotein lipase (LPL) was examined using a human osteosarcoma cell line, osteosarcoma Takase (OST). Treatment of OST cells with TNF-alpha decreased LPL synthesis, resulting in a decrease in expression of activity and secretion of LPL. When OST cells were incubated with glycerol tri[1-14C]palmitate, TNF-alpha decreased dose- and time-dependently the production of 14CO2 and the amounts of radioactivity incorporated into cellular triacylglycerol and phospholipid. The similar reduction of synthesis and activity of LPL as suppression of CO2 production and cellular lipid synthesis indicated that the suppression of 14CO2 production and 14C-labelled lipid synthesis was secondary. TNF-alpha also suppressed expression of proliferating cell nuclear antigen, indicating that it had an anti-proliferative activity on OST cells. The findings suggest that one cause of the anti-proliferative activity of TNF-alpha is the suppression of the LPL-mediated supply of non-esterified fatty acids as an energy source for growth.

Full Text

The Full Text of this article is available as a PDF (395.1 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Ben-Zeev O., Doolittle M. H., Davis R. C., Elovson J., Schotz M. C. Maturation of lipoprotein lipase. Expression of full catalytic activity requires glucose trimming but not translocation to the cis-Golgi compartment. J Biol Chem. 1992 Mar 25;267(9):6219–6227. [PubMed] [Google Scholar]
  2. Brenneman D. E., Spector A. A. Utilization of ascites plasma very low density lipoprotein triglycerides by Ehrlich cells. J Lipid Res. 1974 Jul;15(4):309–316. [PubMed] [Google Scholar]
  3. Celis J. E., Celis A. Cell cycle-dependent variations in the distribution of the nuclear protein cyclin proliferating cell nuclear antigen in cultured cells: subdivision of S phase. Proc Natl Acad Sci U S A. 1985 May;82(10):3262–3266. doi: 10.1073/pnas.82.10.3262. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Cornelius P., Enerback S., Bjursell G., Olivecrona T., Pekala P. H. Regulation of lipoprotein lipase mRNA content in 3T3-L1 cells by tumour necrosis factor. Biochem J. 1988 Feb 1;249(3):765–769. doi: 10.1042/bj2490765. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Doolittle M. H., Ben-Zeev O., Elovson J., Martin D., Kirchgessner T. G. The response of lipoprotein lipase to feeding and fasting. Evidence for posttranslational regulation. J Biol Chem. 1990 Mar 15;265(8):4570–4577. [PubMed] [Google Scholar]
  6. Fransen L., Van der Heyden J., Ruysschaert R., Fiers W. Recombinant tumor necrosis factor: its effect and its synergism with interferon-gamma on a variety of normal and transformed human cell lines. Eur J Cancer Clin Oncol. 1986 Apr;22(4):419–426. doi: 10.1016/0277-5379(86)90107-0. [DOI] [PubMed] [Google Scholar]
  7. Fried S. K., Zechner R. Cachectin/tumor necrosis factor decreases human adipose tissue lipoprotein lipase mRNA levels, synthesis, and activity. J Lipid Res. 1989 Dec;30(12):1917–1923. [PubMed] [Google Scholar]
  8. Grunfeld C., Gulli R., Moser A. H., Gavin L. A., Feingold K. R. Effect of tumor necrosis factor administration in vivo on lipoprotein lipase activity in various tissues of the rat. J Lipid Res. 1989 Apr;30(4):579–585. [PubMed] [Google Scholar]
  9. Haranaka K., Satomi N. Cytotoxic activity of tumor necrosis factor (TNF) on human cancer cells in vitro. Jpn J Exp Med. 1981 Jun;51(3):191–194. [PubMed] [Google Scholar]
  10. Haranaka K., Satomi N., Sakurai A. Antitumor activity of murine tumor necrosis factor (TNF) against transplanted murine tumors and heterotransplanted human tumors in nude mice. Int J Cancer. 1984 Aug 15;34(2):263–267. doi: 10.1002/ijc.2910340219. [DOI] [PubMed] [Google Scholar]
  11. Helson L., Green S., Carswell E., Old L. J. Effect of tumour necrosis factor on cultured human melanoma cells. Nature. 1975 Dec 25;258(5537):731–732. doi: 10.1038/258731a0. [DOI] [PubMed] [Google Scholar]
  12. Hinegardner R. T. An improved fluorometric assay for DNA. Anal Biochem. 1971 Jan;39(1):197–201. doi: 10.1016/0003-2697(71)90476-3. [DOI] [PubMed] [Google Scholar]
  13. Ichiyama A., Nakamura S., Nishizuka Y., Hayaishi O. Enzymic studies on the biosynthesis of serotonin in mammalian brain. J Biol Chem. 1970 Apr 10;245(7):1699–1709. [PubMed] [Google Scholar]
  14. Klebanoff S. J., Vadas M. A., Harlan J. M., Sparks L. H., Gamble J. R., Agosti J. M., Waltersdorph A. M. Stimulation of neutrophils by tumor necrosis factor. J Immunol. 1986 Jun 1;136(11):4220–4225. [PubMed] [Google Scholar]
  15. Lazo P. A. Amino acids and glucose utilization by different metabolic pathways in ascites-tumour cells. Eur J Biochem. 1981 Jun;117(1):19–25. doi: 10.1111/j.1432-1033.1981.tb06297.x. [DOI] [PubMed] [Google Scholar]
  16. Masuno H., Blanchette-Mackie E. J., Chernick S. S., Scow R. O. Synthesis of inactive nonsecretable high mannose-type lipoprotein lipase by cultured brown adipocytes of combined lipase-deficient cld/cld mice. J Biol Chem. 1990 Jan 25;265(3):1628–1638. [PubMed] [Google Scholar]
  17. Masuno H., Blanchette-Mackie E. J., Schultz C. J., Spaeth A. E., Scow R. O., Okuda H. Retention of glucose by N-linked oligosaccharide chains impedes expression of lipoprotein lipase activity: effect of castanospermine. J Lipid Res. 1992 Sep;33(9):1343–1349. [PubMed] [Google Scholar]
  18. Masuno H., Schultz C. J., Park J. W., Blanchette-Mackie E. J., Mateo C., Scow R. O. Glycosylation, activity and secretion of lipoprotein lipase in cultured brown adipocytes of newborn mice. Effect of tunicamycin, monensin, 1-deoxymannojirimycin and swainsonine. Biochem J. 1991 Aug 1;277(Pt 3):801–809. doi: 10.1042/bj2770801. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Matsuno Y., Hirohashi S., Furuya S., Sakamoto M., Mukai K., Shimosato Y. Heterogeneity of proliferative activity in nodule-in-nodule lesions of small hepatocellular carcinoma. Jpn J Cancer Res. 1990 Nov;81(11):1137–1140. doi: 10.1111/j.1349-7006.1990.tb02525.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Miyachi K., Fritzler M. J., Tan E. M. Autoantibody to a nuclear antigen in proliferating cells. J Immunol. 1978 Dec;121(6):2228–2234. [PubMed] [Google Scholar]
  21. Olivecrona T., Chernick S. S., Bengtsson-Olivecrona G., Garrison M., Scow R. O. Synthesis and secretion of lipoprotein lipase in 3T3-L1 adipocytes. Demonstration of inactive forms of lipase in cells. J Biol Chem. 1987 Aug 5;262(22):10748–10759. [PubMed] [Google Scholar]
  22. Price S. R., Olivecrona T., Pekala P. H. Regulation of lipoprotein lipase synthesis by recombinant tumor necrosis factor--the primary regulatory role of the hormone in 3T3-L1 adipocytes. Arch Biochem Biophys. 1986 Dec;251(2):738–746. doi: 10.1016/0003-9861(86)90384-x. [DOI] [PubMed] [Google Scholar]
  23. Price S. R., Olivecrona T., Pekala P. H. Regulation of lipoprotein lipase synthesis in 3T3-L1 adipocytes by cachectin. Further proof for identity with tumour necrosis factor. Biochem J. 1986 Dec 1;240(2):601–604. doi: 10.1042/bj2400601. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. Robbins B. A., de la Vega D., Ogata K., Tan E. M., Nakamura R. M. Immunohistochemical detection of proliferating cell nuclear antigen in solid human malignancies. Arch Pathol Lab Med. 1987 Sep;111(9):841–845. [PubMed] [Google Scholar]
  25. Sakayama K., Masuno H., Miyazaki T., Okumura H., Shibata T., Okuda H. Existence of lipoprotein lipase in human sarcomas and carcinomas. Jpn J Cancer Res. 1994 May;85(5):515–521. doi: 10.1111/j.1349-7006.1994.tb02389.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  26. Semb H., Peterson J., Tavernier J., Olivecrona T. Multiple effects of tumor necrosis factor on lipoprotein lipase in vivo. J Biol Chem. 1987 Jun 15;262(17):8390–8394. [PubMed] [Google Scholar]
  27. Shalaby M. R., Aggarwal B. B., Rinderknecht E., Svedersky L. P., Finkle B. S., Palladino M. A., Jr Activation of human polymorphonuclear neutrophil functions by interferon-gamma and tumor necrosis factors. J Immunol. 1985 Sep;135(3):2069–2073. [PubMed] [Google Scholar]
  28. Shau H. Cytostatic and tumoricidal activities of tumor necrosis factor-treated neutrophils. Immunol Lett. 1988 Jan;17(1):47–51. doi: 10.1016/0165-2478(88)90100-9. [DOI] [PubMed] [Google Scholar]
  29. Spector A. A., Steinberg D. Relationship between fatty acid and glucose utilization in Ehrlich ascites tumor cells. J Lipid Res. 1966 Sep;7(5):657–663. [PubMed] [Google Scholar]
  30. Spector A. A., Steinberg D. The utilization of unesterified palmitate by Ehrlich ascites tumor cells. J Biol Chem. 1965 Oct;240(10):3747–3753. [PubMed] [Google Scholar]
  31. Spector A. A. The importance of free fatty acid in tumor nutrition. Cancer Res. 1967 Sep;27(9):1580–1586. [PubMed] [Google Scholar]
  32. Takasaki Y., Deng J. S., Tan E. M. A nuclear antigen associated with cell proliferation and blast transformation. J Exp Med. 1981 Dec 1;154(6):1899–1909. doi: 10.1084/jem.154.6.1899. [DOI] [PMC free article] [PubMed] [Google Scholar]
  33. Tarentino A. L., Maley F. Purification and properties of an endo-beta-N-acetylglucosaminidase from Streptomyces griseus. J Biol Chem. 1974 Feb 10;249(3):811–817. [PubMed] [Google Scholar]
  34. Tsuchiya H., Morishita H., Tomita K., Ueda Y., Tanaka M. Differentiating and antitumor activities of 1 alpha,25-dihydroxyvitamin D3 in vitro and 1 alpha-hydroxyvitamin D3 in vivo on human osteosarcoma. J Orthop Res. 1993 Jan;11(1):122–130. doi: 10.1002/jor.1100110114. [DOI] [PubMed] [Google Scholar]
  35. Williamson B. D., Carswell E. A., Rubin B. Y., Prendergast J. S., Old L. J. Human tumor necrosis factor produced by human B-cell lines: synergistic cytotoxic interaction with human interferon. Proc Natl Acad Sci U S A. 1983 Sep;80(17):5397–5401. doi: 10.1073/pnas.80.17.5397. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Biochemical Journal are provided here courtesy of The Biochemical Society

RESOURCES